The Current Ratio as of December 2025 (TTM) for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is 1.68

According to HPGC Renmintongtai Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 1.68. This represents a change of 1.95% compared to the average of 1.65 of the last 4 quarters.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Historical Current Ratio (quarterly & annually)

How has 600829.SS Current Ratio performed in the past?

The mean historical Current Ratio of HPGC Renmintongtai Pharmaceutical Corporation over the last ten years is 1.46. The current 1.68 Current Ratio has changed 11.43% with respect to the historical average. Over the past ten years (40 quarters), 600829.SS's Current Ratio was at its highest in in the September 2025 quarter at 1.68. The Current Ratio was at its lowest in in the March 2017 quarter at 1.35.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of HPGC Renmintongtai Pharmaceutical Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Average Current Ratio

How has 600829.SS Current Ratio performed in the past?

The current Current Ratio of HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) Current Ratio vs. Peers

How is 600829.SS’s Current Ratio compared to its peers?

HPGC Renmintongtai Pharmaceutical Corporation’s Current Ratio is greater than Ningbo Menovo Pharmaceutical Co., Ltd. (1.28), less than Fuan Pharmaceutical (Group) Co., Ltd. (2.18), greater than Hunan Fangsheng Pharmaceutical Co., Ltd. (0.86), greater than Jinhe Biotechnology Co. Ltd. (0.94), less than Tianjin Lisheng Pharmaceutical Co.,Ltd. (4.62), less than Tibet Weixinkang Medicine Co., Ltd. (4.07), less than Yabao Pharmaceutical Group Co., Ltd (3.14), less than Beijing Beilu Pharmaceutical Co., Ltd (2.22), less than Teyi Pharmaceutical Group Co.,Ltd (2.01), less than LanZhou Foci Pharmaceutical Co.,Ltd. (3.10),

Build a custom stock screener for HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HPGC Renmintongtai Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HPGC Renmintongtai Pharmaceutical Corporation (600829.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HPGC Renmintongtai Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.